A ligand that Trypanosoma cruzi uses to bind to mammalian cells to initiate infection

被引:28
|
作者
Villalta, F [1 ]
Smith, CM [1 ]
Ruiz-Ruano, A [1 ]
Lima, MF [1 ]
机构
[1] Meharry Med Coll, Sch Med, Dept Microbiol, Nashville, TN 37208 USA
关键词
host cell receptor for Trypanosoma cruzi; gp83 trans-sialidase ligand; host cell receptor for gp83 trans-sialidase; Trypanosoma cruzi ligand; Trypanosoma cruzi attachment and entry;
D O I
10.1016/S0014-5793(01)02853-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We purified a soluble gp83 trans-sialidase (gp83-TSA), from phospholipase C-treated Trypanosoma cruzi trypomastigote membranes, which binds to myoblasts, fibroblasts and macrophages to mediate trypanosome entry. Myoblasts display a single class of receptors for the gp83-TSA present at 4 X 10(4) per myoblast with a K-d of 8 nM. Monovalent Fab fragments of the monoclonal antibody 4A4 specific for gp83-TSA inhibit gp83-TSA binding to myoblasts, fibroblasts and macrophages, block the trypanosomes from attaching to and entering these cells and neutralize T. cruzi infection in BALB/c mice. This is the first demonstration that gp83-TSA is a ligand that T. cruzi uses to attach to cells. (C) 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:383 / 388
页数:6
相关论文
共 50 条
  • [21] Myeloid-Derived Suppressor Cells in Trypanosoma cruzi Infection
    Fresno, Manuel
    Girones, Nuria
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [22] CD8+ T cells in Trypanosoma cruzi infection
    Tarleton, Rick L.
    SEMINARS IN IMMUNOPATHOLOGY, 2015, 37 (03) : 233 - 238
  • [23] Isolation of cardiac mast cells in experimental Trypanosoma cruzi infection
    Meuser-Batista, M.
    Correa, J. R.
    Soares, M. J.
    Henriques-Pons, A.
    TISSUE & CELL, 2008, 40 (05): : 309 - 316
  • [24] Early Trypanosoma cruzi Infection Reprograms Human Epithelial Cells
    Laura Chiribao, Maria
    Libisch, Gabriela
    Parodi-Talice, Adriana
    Robello, Carlos
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [25] CD8+ T cells in Trypanosoma cruzi infection
    Rick L. Tarleton
    Seminars in Immunopathology, 2015, 37 : 233 - 238
  • [26] Glucose uptake in the mammalian stages of Trypanosoma cruzi
    Silber, Ariel M.
    Tonelli, Rnata R.
    Lopes, Camila G.
    Cunha-e-Silva, Narcisa
    Torrecilhas, Ana Claudia T.
    Schumacher, Robert I.
    Colli, Walter
    Alves, Maria Julia M.
    MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2009, 168 (01) : 102 - 108
  • [27] TRYPANOSOMA-CRUZI - MECHANISM OF ENTRY AND INTRACELLULAR FATE IN MAMMALIAN-CELLS
    NOGUEIRA, N
    COHN, Z
    JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 143 (06): : 1402 - 1420
  • [28] AMASTIGOTES OF TRYPANOSOMA-CRUZI SUSTAIN AN INFECTIVE CYCLE IN MAMMALIAN-CELLS
    LEY, V
    ANDREWS, NW
    ROBBINS, ES
    NUSSENZWEIG, V
    FASEB JOURNAL, 1988, 2 (04): : A883 - A883
  • [29] AMASTIGOTES OF TRYPANOSOMA-CRUZI SUSTAIN AN INFECTIVE CYCLE IN MAMMALIAN-CELLS
    LEY, V
    ANDREWS, NW
    ROBBINS, ES
    NUSSENZWEIG, V
    JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (02): : 649 - 659
  • [30] Nelfinavir and lopinavir impair Trypanosoma cruzi trypomastigote infection in mammalian host cells and show anti-amastigote activity
    Sangenito, Leandro S.
    d'Avila-Levy, Claudia M.
    Branquinha, Marta H.
    Santos, Andre L. S.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2016, 48 (06) : 703 - 711